Menu Search
Equities

Urteste SA

URT:WSE

Urteste SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (PLN)95.20
  • Today's Change3.20 / 3.48%
  • Shares traded505.00
  • 1 Year change-13.45%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in PLNView more

In 2023, cash reserves at Urteste SA fell by 2.30m. Cash Flow from Financing totalled 27.43m or -- of revenues. In addition the company used 5.32m for operations while cash used for investing totalled 24.40m.
Cash flow per share-3.48
Price/Cash flow per share--
Book value per share18.74
Tangible book value per share18.67
More ▼

Balance sheet in PLNView more

Urteste SA uses little debt in its capital structure as supported by a debt to capital ratio of 2.63%.
Current ratio17.07
Quick ratio16.97
Total debt/total equity0.027
Total debt/total capital0.0263
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.